Therefore this technology could improve the development of T cell diagnostics in a variety of viral, cancer and autoimmune diseases and may facilitate a novel strategy for the expansion of protein-specific CD8+ T cells for therapeutic applications. The gene discussed is CD8A; the disease is cancer.